Flt3L Combined with Rapamycin Promotes Cardiac Allograft Tolerance by Inducing Regulatory Dendritic Cells and Allograft Autophagy in Mice

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xiong, Ali ^a   Duan, Lihua ^a   Chen, Jie ^a   Fan, Zhigang ^a   Zheng, Fang ^a   Tan, Zheng ^a   Gong, Feili ^a,b,c   Fang, Min ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; INTERLEUKIN 10; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENTIATION; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; LOW DRUG DOSE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; TRANSPLANTATION TOLERANCE;

ANIMALS; AUTOPHAGY; DENDRITIC CELLS; HEART TRANSPLANTATION; IMMUNE TOLERANCE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

MURINAE; MUS;

EID: 84867025677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046230     Document Type: Article

References (53)

1. Sayegh MH, Carpenter CB (2004) Transplantation 50 years later-progress, challenges, and promises. N Engl J Med. 2004/12/24 ed. 2761-2766.
2. Fishman JA, (2007) Medical progress: Infection in solid-organ transplant recipients. New England Journal of Medicine 357: 2601-2614.
3. Tantravahi J, Womer KL, Kaplan B, (2007) Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med 58: 369-385.
4. Morelli AE, Thomson AW, (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7: 610-621.
5. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
6. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
7. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR, (1991) A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65: 1143-1152.
8. Schmid MA, Kingston D, Boddupalli S, Manz MG, (2010) Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 234: 32-44.
9. Abe M, Wang Z, de Creus A, Thomson AW, (2005) Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am J Transplant 5: 1808-1819.
10. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, et al. (1993) Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 17: 1127-1152.
11. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, et al. (1996) The lost chord: microchimerism and allograft survival. Immunol Today 17: 577-584; discussion 588.
12. Lunemann JD, Munz C, (2009) Autophagy in CD4+ T-cell immunity and tolerance. Cell Death Differ 16: 79-86.
13. Schmid D, Pypaert M, Munz C, (2007) Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26: 79-92.
14. Steinman RM, Banchereau J, (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
15. Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, et al. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
16. Fu F, Li Y, Qian S, Lu L, Chambers F, et al. (1996) Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62: 659-665.
17. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, et al. (1995) Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60: 1366-1370.
18. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, et al. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 9: 1253-1260.
19. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ, (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243: 240-246.
20. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P, (2000) Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 275: 992-998.
21. Saunders RN, Metcalfe MS, Nicholson ML, (2001) Rapamycin in transplantation: a review of the evidence. Kidney Int 59: 3-16.
22. Kahan BD, Camardo JS, (2001) Rapamycin: clinical results and future opportunities. Transplantation 72: 1181-1193.
23. Steptoe RJ, Fu F, Li W, Drakes ML, Lu L, et al. (1997) Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol 159: 5483-5491.
24. Ge W, Jiang J, Baroja ML, Arp J, Zassoko R, et al. (2009) Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 9: 1760-1772.
25. Coates PT, Duncan FJ, Colvin BL, Wang Z, Zahorchak AF, et al. (2004) In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 77: 1080-1089.
26. Emmanouilidis N, Guo Z, Dong Y, Newton-West M, Adams AB, et al. (2006) Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells. Transplantation 81: 455-462.
27. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, et al. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114: 280-290.
28. Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, et al. (2002) The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196: 1099-1104.
29. O'Connell PJ, Li W, Wang Z, Specht SM, Logar AJ, et al. (2002) Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol 168: 143-154.
30. Liu YJ, (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
31. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N, (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238.
32. Velthuis JH, Mol WM, Weimar W, Baan CC, (2006) CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6: 2955-2964.
33. Baan CC, Velthuis JH, van Gurp EA, Mol WM, Klepper M, et al. (2007) Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients. Clin Transplant 21: 63-71.
34. Velthuis JH, Hesselink DA, Hendrikx TK, van der Mast BJ, Klepper M, et al. (2007) Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients. Transpl Immunol 18: 159-165.
35. Hendrikx TK, van Gurp EA, Sewgobind VD, Mol WM, Schoordijk W, et al. (2009) Generation of donor-specific regulatory T-cell function in kidney transplant patients. Transplantation 87: 376-383.
36. Wang Z, Fu XY, Shi BY, Qian YY, Xiao L, et al. (2009) Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients. Transplant Proc 41: 1574-1576.
37. Yoshizawa A, Ito A, Li Y, Koshiba T, Sakaguchi S, et al. (2005) The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 37: 37-39.
38. Lee MKt, Moore DJ, Jarrett BP, Lian MM, Deng S, et al. (2004) Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 172: 6539-6544.
39. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, et al. (2006) Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177: 8338-8347.
40. Battaglia M, Stabilini A, Roncarolo MG, (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
41. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, et al. (2010) In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32: 227-239.
42. Fischer RT, Turnquist HR, Wang Z, Beer-Stolz D, Thomson AW, (2011) Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo. Transpl Immunol 25: 20-26.
43. Trandem K, Zhao J, Fleming E, Perlman S, (2011) Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 186: 3642-3652.
44. Zhang N, Bevan MJ, (2011) CD8(+) T cells: foot soldiers of the immune system. Immunity 35: 161-168.
45. Suciu-Foca N, Manavalan JS, Scotto L, Kim-Schulze S, Galluzzo S, et al. (2005) Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol 5: 7-11.
46. Lin YX, Wang LL, Yan LN, Cai P, Li B, et al. (2009) Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int 8: 241-246.
47. Strioga M, Pasukoniene V, Characiejus D, (2011) CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 134: 17-32.
48. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, et al. (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128: 931-946.
49. Gotoh K, Lu Z, Morita M, Shibata M, Koike M, et al. (2009) Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation. Autophagy 5: 351-360.
50. Corry RJ, Winn HJ, Russell PS, (1973) Heart transplantation in congenic strains of mice. Transplant Proc 5: 733-735.
51. Huang Y, Yin H, Han J, Huang B, Xu J, et al. (2007) Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 7: 799-808.
52. Yu G, Fang M, Gong M, Liu L, Zhong J, et al. (2008) Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells. Transpl Immunol 18: 208-219.
53. Lyons AB, (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243: 147-154.